Cargando…
The Study of Overexpression of Peroxiredoxin-2 Reduces MPP(+)-Induced Toxicity in the Cell Model of Parkinson’s Disease
Parkinson’s disease (PD) is a chronic neurodegenerative disorder characterized by dopaminergic neuron loss, which is related to excessive reactive oxygen species (ROS) accumulation. Endogenous peroxiredoxin-2 (Prdx-2) has potent anti-oxidative and anti-apoptotic effects. Proteomics studies revealed...
Autores principales: | Liu, Menghao, Zuo, Shuqian, Guo, Xing, Peng, Junyu, Xing, Yaoping, Guo, Yanjie, Li, Chaokun, Xing, Hongxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182157/ https://www.ncbi.nlm.nih.gov/pubmed/36808393 http://dx.doi.org/10.1007/s11064-023-03880-5 |
Ejemplares similares
-
LINC00667 regulates MPP(+)‐induced neuronal injury in Parkinson’s disease
por: Huo, Xinlong, et al.
Publicado: (2022) -
High-Resolution Respirometry Reveals MPP(+) Mitochondrial Toxicity Mechanism in a Cellular Model of Parkinson’s Disease
por: Risiglione, Pierpaolo, et al.
Publicado: (2020) -
The overexpression of peroxiredoxin-4 affects the progression of idiopathic pulmonary fibrosis
por: Hanaka, Tetsuya, et al.
Publicado: (2019) -
Costunolide and Parthenolide Ameliorate MPP+ Induced Apoptosis in the Cellular Parkinson’s Disease Model
por: Arslan, Mehmet Enes, et al.
Publicado: (2023) -
Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease
por: Muroyama, Akiko, et al.
Publicado: (2012)